CoSt Turns Audit Backlogs Into One Growth Bet

A typical growth audit creates a familiar problem. The team receives a long list of conversion leaks, messaging issues, SEO ideas and experiments, then has to decide which one deserves the next week of work. The analysis may be useful, but the backlog still has no clear starting point.

CoSt is built for that moment. It takes a website URL and turns its analysis into one prioritised growth decision for the next 30 days. Its defining output is not a larger collection of findings. It is a Primary Bet, accompanied by a Kill List that explains why other options were rejected.

That makes CoSt less like a general analytics dashboard and more like a decision layer after an audit. The distinction matters because many teams do not lack ideas. They lack a defensible way to choose between them.

From a website URL to a decision

The process starts with a site URL. CoSt says its pipeline models the intended customer and brand, studies the market, reviews competitor websites and pricing, diagnoses conversion problems, and scores possible opportunities. The landing page describes live competitor research rather than assumptions about a market, although that remains a claim about how the service operates rather than something a reader can independently verify from the product page.

The output is intended to arrive in roughly six minutes. It includes a named hypothesis, three actions to ship during the first week, an urgency assessment, and an explanation of the evidence behind the choice. The scoring considers factors such as alignment with the diagnosis, competitive whitespace, audience fit and implementation speed.

There is also an “If Wrong” section. It addresses the downside of acting on the recommendation by considering time, budget and reversibility. That is a useful inclusion for small teams, where the cost of a poor experiment is often less about media spend and more about losing a week of engineering or marketing capacity.

CoSt offers a free plan with a paid upgrade. The free option is positioned as a quick diagnosis, while the fuller analysis adds the Primary Bet, Kill List and supporting decision material.

The useful part is what gets rejected

The Kill List is the product's clearest answer to the prioritisation problem. CoSt says it evaluates multiple growth opportunities, then records which ones lost and why. A content push might be rejected because it takes too long for the current window. A referral programme might be a poor fit if the business lacks enough happy customers. A new feature could lose because it requires engineering work before the core page converts.

These examples point to a practical benefit. A team can disagree with the recommendation without having to reconstruct the entire reasoning process. It can inspect whether the rejected idea lost on speed, feasibility, expected impact or audience fit. The system does not remove judgement, but it gives that judgement a more concrete object to challenge.

The product's example output also shows a single score for the winning bet and lower-ranked alternatives. Such scores can help create a shared language in a growth meeting, but they should not be treated as measured probabilities. They are generated assessments based on the available site and market evidence. A high score is a prioritisation signal, not proof that an experiment will work.

That distinction is important for a tool that presents itself as an alternative to an audit report. A decision is only useful if the team can test it quickly and stop when the evidence turns against it.

It goes beyond the recommendation, sometimes

On the fuller plan, CoSt supplies execution material such as rewritten hero copy, advertising variants, email copy, landing page text and budget allocation options. This could reduce the gap between choosing an experiment and preparing it for launch. The reports can also include a 90-day roadmap, while the central bet is framed around a 30-day period.

The landing page describes a tracker for the period after the initial recommendation. Teams can log what shipped, record blockers and check progress before deciding whether to run another analysis or mark the bet as successful. That makes the service more than a one-off report in its intended workflow, although the value of the tracker depends on the team actually running the test and measuring the agreed metric.

The service also flags medical, legal or brand risks for human review rather than presenting every recommendation as ready to publish. That is a sensible boundary. It does not make the generated copy safe by default, and a company still needs someone responsible for checking claims, compliance and brand fit.

Who CoSt is actually for

The strongest fit is a founder, growth team or agency that already has an audit, consultant teardown, heatmap review or similar backlog. Those users have enough material to make a decision but not enough time to debate every possible improvement. An agency may also use the service as a repeatable input for client work, provided it is willing to review the output rather than pass it through unchanged.

The limitation is just as clear: CoSt is not a substitute for discovering the business problem in the first place. It assumes a website that can be inspected and a team able to ship and measure a recommendation. It is a weaker fit for an early company with no meaningful traffic, unclear customer definition or no agreed metric. It also runs on the web only, so it is not a native desktop tool for an offline research workflow.

CoSt solves a narrow but common problem: deciding what to do after analysis has produced too many plausible options. It is for teams that need a ranked bet and a reason to stop pursuing the rest. It is not for teams looking for exhaustive research, guaranteed results or a replacement for human review before launch.